Vulcan Value Partners LLC decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 92.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 67,309 shares of the healthcare conglomerate’s stock after selling 845,365 shares during the quarter. UnitedHealth Group accounts for about 0.9% of Vulcan Value Partners LLC’s portfolio, making the stock its 21st largest position. Vulcan Value Partners LLC’s holdings in UnitedHealth Group were worth $27,976,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also modified their holdings of UNH. Arizona State Retirement System boosted its position in shares of UnitedHealth Group by 1.5% during the second quarter. Arizona State Retirement System now owns 251,862 shares of the healthcare conglomerate’s stock worth $104,681,000 after purchasing an additional 3,679 shares in the last quarter. West Family Investments Inc. lifted its holdings in UnitedHealth Group by 214.7% during the second quarter. West Family Investments Inc. now owns 3,100 shares of the healthcare conglomerate’s stock worth $1,288,000 after acquiring an additional 2,115 shares in the last quarter. Bank OZK bought a new stake in shares of UnitedHealth Group in the second quarter worth about $268,000. Paragon Capital Management Ltd acquired a new stake in shares of UnitedHealth Group during the second quarter worth about $267,000. Finally, Nykredit A S acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at approximately $89,666,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.
UnitedHealth Group Stock Up 1.0%
Shares of NYSE UNH traded up $4.12 during mid-day trading on Tuesday, hitting $401.25. The company had a trading volume of 7,048,300 shares, compared to its average volume of 7,640,271. UnitedHealth Group Incorporated has a one year low of $255.96 and a one year high of $461.62. The company has a market capitalization of $360.16 billion, a PE ratio of 25.82, a price-to-earnings-growth ratio of 1.49 and a beta of 0.61. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The firm has a 50-day simple moving average of $410.91 and a two-hundred day simple moving average of $366.22.
UnitedHealth Group Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th will be given a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend is Monday, September 14th. UnitedHealth Group’s dividend payout ratio is 59.72%.
Insider Activity at UnitedHealth Group
In other news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. This trade represents a 7.09% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 0.19% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
Several research analysts have recently weighed in on UNH shares. Erste Group Bank cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, August 27th. Morgan Stanley boosted their price objective on shares of UnitedHealth Group from $468.00 to $529.00 and gave the company an “overweight” rating in a research report on Friday, July 17th. Mizuho lifted their price target on UnitedHealth Group from $470.00 to $493.00 and gave the company an “outperform” rating in a research note on Monday, July 20th. HC Wainwright set a $492.00 price objective on UnitedHealth Group in a report on Wednesday, May 27th. Finally, Robert W. Baird upgraded UnitedHealth Group from an “underperform” rating to a “neutral” rating and boosted their target price for the company from $287.00 to $453.00 in a research note on Thursday, July 16th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average target price of $456.56.
Check Out Our Latest Stock Analysis on UNH
UnitedHealth Group Company Profile
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
- Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock
- Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement
- Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
